Sunscreen and vitamin D

Asking for Preferences

Reading File

Finding Sources

Searching PubMed

sunscreen AND "vitamin D" synthesis

Reading File

Reading Article

Reading File

Here's a thorough breakdown of whether sunscreen blocks vitamin D synthesis:

Does Sunscreen Block Vitamin D Synthesis?

The Mechanism

Vitamin D3 (cholecalciferol) is synthesized in the skin when UVB radiation (peak action spectrum: 295–305 nm) converts 7-dehydrocholesterol to previtamin D3, which then isomerizes to vitamin D3 by heat. The same UVB wavelengths responsible for vitamin D synthesis are also responsible for DNA damage and skin carcinogenesis. Sunscreens work by absorbing UVB, so theoretically they should reduce vitamin D production.

--- Goodman & Gilman's, p. (Table 52-1 section); Fitzpatrick's Dermatology, p. 3658

In Theory: Yes, Sunscreen Can Block It

In vitro studies consistently show sunscreen blocks UVB, which is required for vitamin D3 production.
Applying the WHO-recommended amount of sunscreen (SPF 15+) can abolish endogenous vitamin D production under ideal (laboratory) conditions. — Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 71–73
SPF 8 or greater has been shown to inhibit cutaneous vitamin D synthesis. — National Kidney Foundation Primer on Kidney Diseases

In Practice: The Impact is Modest

Real-world evidence consistently shows the theoretical risk rarely materializes into clinical vitamin D deficiency in the general population, for several reasons:

People under-apply sunscreen — the amount used in practice is far less than in standardized testing, so the actual SPF and UV-blocking effect is lower.
Sunscreen users tend to spend more time outdoors, compensating for reduced per-minute synthesis.
Only a small UVB dose is needed — for a Fitzpatrick Type II individual, just 5 minutes of midday summer sun, 2–3 times per week to the face, arms, and hands is sufficient to meet physiologic vitamin D requirements. Even with imperfect sunscreen application, this threshold is commonly exceeded.

"Normal usage of sunscreens does not generally result in vitamin D insufficiency." — Fitzpatrick's Dermatology (Chap. 3658), citing a comprehensive review of published evidence

Who IS at Risk?

Certain groups who practice diligent photoprotection do show significantly lower 25-hydroxyvitamin D [25(OH)D] levels:

Patients with lupus erythematosus or erythropoietic protoporphyria (conditions requiring strict light avoidance)
Individuals with dark skin (higher melanin = natural UV filter, requires more UVB exposure)
The elderly, homebound individuals, and those in northern latitudes
Patients with cystic fibrosis, congenital ichthyoses, or other malabsorptive states where dietary vitamin D absorption is also impaired

The Numbers (Latest Evidence)

A 2025 systematic review and meta-analysis (Gatta & Cappelli, Endocrine Practice, 22 studies, 9,470 participants) found:

Sunscreen use was associated with a mean reduction of ~2 ng/mL in serum 25(OH)D (95% CI: −3 to −1 ng/mL), with low heterogeneity across studies (I² = 37%).

This is a statistically significant but clinically small reduction. Normal 25(OH)D levels are 15–50 ng/mL; a 2 ng/mL reduction is unlikely to push most people into deficiency.

— Sunscreen and 25-Hydroxyvitamin D Levels: Friends or Foes? — Endocrine Practice, 2025 (PMID: 40246233)

Practical Recommendations

Group	Recommendation
General population	Use sunscreen freely; vitamin D deficiency from sunscreen alone is unlikely
Those at risk (strict photoprotection, dark skin, elderly, northern latitude)	Use vitamin D supplements (600 IU/day, up to 800 IU for elderly) + 1 g calcium
At-risk groups	Do not rely on intentional unprotected sun exposure for vitamin D — the DNA damage risk outweighs the benefit

Because the UVB action spectrum for vitamin D synthesis overlaps completely with that for DNA damage and skin carcinogenesis, intentional unprotected sun exposure is not recommended as a strategy to raise vitamin D levels. Dietary sources (oily fish, fortified milk, eggs) and supplements are a safer alternative for those with low levels.

— Fitzpatrick's Dermatology, p. 3658; Goodman & Gilman's, p. 71

This is a shared conversation. Sign in to Orris to start your own chat.